ANNUAL REPORT 2005
  The Year in Brief
  CEO's Review
  Corporate Governance
  Financial Risk Management
  Corporate Responsibility
BUSINESS UNITS
  Tamro Sweden
  Tamro Denmark (Nomeco)
  Tamro Finland
  Tamro Norway (Apokjeden)
  Tamro Estonia
  Tamro Latvia
  Tamro Lithuania
Tamro MedLab
FINANCIAL STATEMENTS
  Site Map/
Download Centre
   
suomeksi

Tamro MedLab

  • Tamro MedLab’s net sales for the accounting year in 2005/2006 amounted to EUR 133 million, down 1% from the previous 13-month financial year.

Markets and operating environment

Tamro MedLab Group’s activities are divided into two business units: Med and Lab. Med sells, markets and distributes products to hospitals and healthcare facilities in the Nordic and Baltic countries, while Lab sells and markets laboratory supplies and equipment in Finland, Sweden and Norway for industrial, research and hospital laboratories.

Manufacturers continued to consolidate on a global level. Customers are also forming purchase groups to rationalise their operations and obtain more favourable purchase conditions.

Financial performance and operations

  2005/2006
(12 months)
2004/2005
(13 months)
Change
Net sales, EUR million 133 134 -1 %
Employees, average 274 263 4 %

Tamro MedLab’s net sales for the accounting year in 2005/2006 amounted to EUR 133 million, down 1% from the previous 13-month financial year.

The best sales development was in Norway and Denmark. In Baltic countries, especially in Estonia and Lithuania the sales development was very good.

Delay in the launch of Arkray’s new blood sugar meter caused challenges in marketing and selling. In Denmark business was strengthened by acquiring the primary care -oriented Danpleje A/S. After the merger Tamro MedLab is second largest company operating in Denmark’s health care market.

Tamro MedLab’s own brand, OneMed, developed according to plans. We supplemented new products under OneMed-brand, mainly surgery textiles. Sales of OneMed-products developed well. OneMed will still be a strong focus area in the future.

Personnel

During the financial year, Tamro MedLab employed an average of 274 (263) employees.

Outlook for 2006

The Nordic economies continue their strong growth and we expect stable development in the health care sector. However, the scarcity of resources can create difficulties in many areas in healthcare. The planned communal re-organization in Finland can create changes the way healthcare services are produced. Tamro MedLab continues to strengthen its market position in all its operating countries.


Jorma Turunen
Tamro MedLab
 

 

  Tamro Web Annual Report 2005/2006. Published 11 May 2005. Copyright © Tamro Corporation 2006. All rights reserved.